Widespread Off-Label Use Could Ensure Injectable Bacitracin's Future

 
• By Sue Sutter
  
Medication drug needle syringe
The US FDA is asking its external experts whether bacitracin injection should remain on the market. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers